Rural communities in low- and middle-income countries face specific challenges in accessing health care. And yet, these communities are often the most vulnerable and most in need. So how can we overcome these barriers to provide everyone with the health care they have a right to? How do we maximize the available healthcare resources to effectively address inequalities and ensure sustainable service delivery?
Data for Impact (D4I) is hosting a one-hour webinar, on April 5 at 9 a.m. EDT, to share experience from multiple projects in adapting and managing tools to strengthen the capacity of organizations in low- and medium-resource countries to conduct public health programs independently.
Community mobilization and interpersonal communication are critical for engaging communities to create awareness and understanding about VMMC and generate demand for VMMC services. While there are other demand creation activities and approaches, such as use of mass media and social media, this guide focuses on community mobilization for VMMC services.
Public dissemination of tools that have been created for existing PrEP demonstration projects aimed at guiding PrEP implementation for different populations can facilitate the development of ongoing and future efforts.
Panagora Group's Monitoring, Evaluation, Research, and Learning (MERL) Activity supports USAID/South Africa’s bilateral Health Office by working collaboratively with health office staff to achieve their overall goals by creatively finding innovative solutions, supplementing and complementing their existing staff capacity, and as appropriate enhancing capacity in performance management; evaluation and research; and systematic collaboration, continuous learning, and adaptive management. We are looking for creative, dynamic, results focused and experienced professionals to be part of a pool of consultants that we can call on to support USAID/South Africa’s bilateral Health Office with a variety of needs in the area of HIV and AIDS.
The PrEP Costing Guidelines provide a framework for estimating the cost of providing pre-exposure prophylaxis (PrEP), which is the use of antiretroviral (ARV) drugs for preventing the acquisition of HIV infection.